Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Thomas, Herzinger"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
As indications for immune checkpoint inhibitors for breast cancer continue to expand, rare toxicities will emerge that require careful consideration and multidisciplinary management. We report the case of a 40-year-old female receiving neoadjuvant pe
Externí odkaz:
https://doaj.org/article/21cae8db027d49f18588da0dc8ef28be
Publikováno v:
Case Reports in Dermatology, Vol 13, Iss 2, Pp 379-383 (2021)
Tattoos have become increasingly popular worldwide making adverse effects from tattoos a growing concern. In our report, we present a 51-year-old man who developed an unusual allergic reaction to the red ink portions of his tattoos that coincided wit
Externí odkaz:
https://doaj.org/article/1b5472b4853745b58256fc1ff202fc58
Autor:
Cristel Ruini, Benjamin M. Clanner-Engelshofen, Markus Heppt, Thomas Herzinger, Miklós Sárdy, Thomas Ruzicka, Lars E. French, Markus Reinholz
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 16, p adv00259 (2020)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/61ffea19ce9d4cd388117662bf336389
Publikováno v:
SAGE Open Medical Case Reports, Vol 8 (2020)
Infliximab is a tumor necrosis factor-alpha inhibitor used to treat a range of inflammatory diseases. Most reports of cutaneous eruptions from tumor necrosis factor-alpha inhibitors have described the paradoxical development of psoriasis or psoriasif
Externí odkaz:
https://doaj.org/article/f8ec3b3d7f59467aafc317e7b95732aa
Autor:
Peter Reilich, Christian Schmidt, Markus Reinholz, Thomas Herzinger, Angela Abicht, Miriam Hiebeler, Benedikt Schoser, Michael J. Flaig
Publikováno v:
Neuromuscular Disorders. 32:65-70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e374974cc0074b7ec265652cf93656b0
https://doi.org/10.1016/j.nmd.2021.11.009
https://doi.org/10.1016/j.nmd.2021.11.009
Publikováno v:
Case Reports in Dermatology
Case Reports in Dermatology, Vol 13, Iss 2, Pp 379-383 (2021)
Case Reports in Dermatology, Vol 13, Iss 2, Pp 379-383 (2021)
Tattoos have become increasingly popular worldwide making adverse effects from tattoos a growing concern. In our report, we present a 51-year-old man who developed an unusual allergic reaction to the red ink portions of his tattoos that coincided wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8be114f0b7c05105d0e9abdc50df8a
http://europepmc.org/articles/PMC8339442
http://europepmc.org/articles/PMC8339442
Autor:
Thomas Herzinger, Silke C. Hofmann
Publikováno v:
Die Dermatologie. 73:667-668
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72a38cb2846eb5eedda08b15c144113a
https://doi.org/10.1007/s00105-022-05041-1
https://doi.org/10.1007/s00105-022-05041-1
Autor:
Thomas Herzinger
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 20:1271-1271
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::774ce84f17a1158ecaf67b339e88803d
https://doi.org/10.1111/ddg.14873_g
https://doi.org/10.1111/ddg.14873_g
Autor:
Thomas Herzinger
Publikováno v:
Braun-Falco´s Dermatology ISBN: 9783662587133
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be52e9ea55556bf161198706bbadeb8
https://doi.org/10.1007/978-3-662-58713-3_75-1
https://doi.org/10.1007/978-3-662-58713-3_75-1
Publikováno v:
SAGE Open Medical Case Reports
SAGE Open Medical Case Reports, Vol 8 (2020)
SAGE Open Medical Case Reports, Vol 8 (2020)
Infliximab is a tumor necrosis factor-alpha inhibitor used to treat a range of inflammatory diseases. Most reports of cutaneous eruptions from tumor necrosis factor-alpha inhibitors have described the paradoxical development of psoriasis or psoriasif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebae8f280effd8b5bfafd306c318a67b
http://europepmc.org/articles/PMC6987482
http://europepmc.org/articles/PMC6987482